Advertisement
U.S. markets closed

Syra Health Corp. (SYRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.7350-0.3150 (-15.37%)
At close: 04:00PM EST
1.7600 +0.03 (+1.44%)
After hours: 07:58PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/20/2024
Current
9/30/2023
Market Cap (intraday)
13.16M17.93M
Enterprise Value
15.00M19.77M
Trailing P/E
N/AN/A
Forward P/E
N/AN/A
PEG Ratio (5 yr expected)
N/AN/A
Price/Sales (ttm)
3.133.87
Price/Book (mrq)
N/AN/A
Enterprise Value/Revenue
2.6212.50
Enterprise Value/EBITDA
-6.11-60.30

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-31.67%
S&P500 52-Week Change 325.42%
52 Week High 38.3700
52 Week Low 30.8120
50-Day Moving Average 31.3610
200-Day Moving Average 31.5283

Share Statistics

Avg Vol (3 month) 32M
Avg Vol (10 day) 311.18M
Shares Outstanding 55.59M
Implied Shares Outstanding 65.14M
Float 82.86M
% Held by Insiders 117.45%
% Held by Institutions 10.49%
Shares Short (Jan 31, 2024) 4139.37k
Short Ratio (Jan 31, 2024) 40.33
Short % of Float (Jan 31, 2024) 4N/A
Short % of Shares Outstanding (Jan 31, 2024) 41.31%
Shares Short (prior month Dec 29, 2023) 45.88k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sep 30, 2023

Profitability

Profit Margin -44.72%
Operating Margin (ttm)-21.69%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)5.71M
Revenue Per Share (ttm)1.25
Quarterly Revenue Growth (yoy)4.50%
Gross Profit (ttm)N/A
EBITDA -2.46M
Net Income Avi to Common (ttm)-2.56M
Diluted EPS (ttm)-0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.01k
Total Cash Per Share (mrq)0
Total Debt (mrq)2.47M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.52
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)-2.22M
Levered Free Cash Flow (ttm)N/A